We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

34 hedge funds and large institutions have $24.1M invested in Histogen Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less funds holding

Funds holding: 3834 (-4)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

35% less call options, than puts

Call options by funds: $577K | Put options by funds: $889K

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

47% less capital invested

Capital invested by funds: $45.6M → $24.1M (-$21.6M)

Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
9
Reduced
12
Closed
10
Calls
$577K
Puts
$889K
Net Calls
-$312K
Net Calls Change
-$616K

HSTO Hedge Fund Activity: Q3 2014 in Review

34 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2014, worth a combined $24.1M — down 47% from $45.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of HSTO and 6 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 9 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $680K. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $4.09M sold.

  • 34 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2014, down from 38 in Q2 2014.
  • Funds reported $24.1M of Histogen Inc. Common Stock stock for Q3 2014, down 47% quarter-over-quarter.
  • 6 funds opened new Histogen Inc. Common Stock positions in Q3 2014 and 10 closed out, a net change of -4 holders.
  • The largest Histogen Inc. Common Stock buyer in Q3 2014 was Susquehanna International Group, an estimated $680K added.
  • The largest Histogen Inc. Common Stock seller in Q3 2014 was Janus Henderson Investors US, an estimated $4.09M sold.

Based on aggregated 13F filings for Q3 2014.